Medicines

Gilead seeks to develop products that represent advancements by offering enhanced modes of delivery, more convenient treatment regimens, improved resistance profiles, reduced side effects and greater efficacy. Through our own research and partnerships with universities, medical research institutions and global pharmaceutical leaders, Gilead is rapidly and efficiently making scientific and clinical advancements that raise the standard for new therapeutics that treat life-threatening diseases.


HIV/AIDS

atripla

Atripla®

efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg
biktarvy

Biktarvy®

bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg
Complera pill

Complera®

emtricitabine 200 mg/rilpivirine 25 mg/tenofovir disoproxil fumarate 300 mg
Genvoya pill

Genvoya®

elvitegravir 150 mg/cobicistat 150 mg/ emtricitabine 200 mg/tenofovir alafenamide 10 mg
Odefsey pill

Odefsey®

emtricitabine 200 mg/rilpivirine 25 mg/ tenofovir alafenamide 25 mg
Stribild pill

Stribild®

elvitegravir 150 mg/cobicistat 150 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg

Cardiovascular

Inflammation/Respiratory

Tamiflu pill

Tamiflu®

oseltamivir phosphate 75 mg

Other Medicines

Ambisome vial

AmBisome®

amphotericin b liposome for injection 50 mg/vial
Macugen injection

Macugen®

pegaptanib sodium injection 0.3 mg